Understanding Pyridoxine-Dependent Epilepsy and Dietary Management: A Guide for Families.

Dr. Houten’s work on substrate reduction therapy for GA1 and its implications for related pathways such as PDE offers a glimpse into the future of treatment for rare genetic disorders.

We’re excited to share a unique opportunity for you to contribute directly to the future of PDE research.

This blog post introduces the CHARLIE Consortium, a group of researchers dedicated to studying Pyridoxine-Dependent Epilepsy (PDE).

A recent study has shed new light on how PDE affects energy production in the body, offering fresh insights that could potentially lead to better treatments.